Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Fitness and cognitive processing speed in persons with multiple sclerosis: A cross-sectional investigation.
The feasibility and short-term benefits of Blue Prescription: a novel intervention to enable physical activity for people with multiple sclerosis.
Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis.
Individual Face-to-Face Cognitive Behavioural Therapy in Multiple Sclerosis: A Qualitative Study.
Three Minor Diterpenoids with Three Carbon Skeletons from Euphorbia peplus.
Acute liver toxicity due to methylprednisolone: Consider this diagnosis in the context of autoimmunity.
Chronic cerebrospinal venous insufficiency is not associated with multiple sclerosis and its severity: a blind-verified study.
[Indexes of integrative activity of motor system in norm and at neuromotor pathology].
Evaluation of brainstem involvement in multiple sclerosis.
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.
Neuro-Behçet's disease, its mimickers and anti-TNF therapy: a case-based review.
[Depression and neurological diseases].
Epidemiology of neurologically disabling disorders.
Rationale and design of a randomized controlled, clinical trial investigating a comprehensive exercise stimulus for improving mobility disability outcomes in persons with multiple sclerosis.
Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology.
Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related items.
Development and validation of the multiple sclerosis questionnaire for the evaluation of job difficulties (MSQ-Job).
Behavioural changes observed in demyelination model shares similarities with white matter abnormalities in humans.
Novel diagnostic tools and solutions for multiple sclerosis treatment: a patent review (2009 - 2014).
Effective communication at the point of multiple sclerosis diagnosis.
Strategies used by individuals with multiple sclerosis and with mild disability to maintain dynamic stability during a steering task.
Transcription factor induction of human oligodendrocyte progenitor fate and differentiation.
Is total duration of distal compound muscle action potential better than negative peak duration in the diagnosis of chronic inflammatory demyelinating polyneuropathy?
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning.
Progranulin genetic polymorphisms influence progression of disability and relapse recovery in multiple sclerosis.
Pages
« first
‹ previous
…
485
486
487
488
489
490
491
492
493
…
next ›
last »